CS
Candriam SCA Portfolio holdings
AUM
$17.3B
This Quarter Return
-4.69%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$14.7B
AUM Growth
+$14.7B
(-6.2%)
Cap. Flow
+$67.3M
Cap. Flow
% of AUM
0.46%
Top 10 Holdings %
Top 10 Hldgs %
23.64%
Holding
885
New
75
Increased
356
Reduced
296
Closed
67
Top Buys
| 1 |
Walt Disney
DIS
|
$85.6M |
| 2 |
Merck
MRK
|
$72.8M |
| 3 |
Adobe
ADBE
|
$52.2M |
| 4 |
Booking.com
BKNG
|
$34.7M |
| 5 |
ServiceNow
NOW
|
$30.1M |
Top Sells
| 1 |
Amgen
AMGN
|
$54M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$44.5M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
$36.4M |
| 4 |
Salesforce
CRM
|
$36.2M |
| 5 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$30.1M |
Sector Composition
| 1 | Healthcare | 29.36% |
| 2 | Technology | 26.37% |
| 3 | Financials | 8.78% |
| 4 | Communication Services | 7.86% |
| 5 | Consumer Discretionary | 7.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EPAY
201
DELISTED
Bottomline Technologies Inc
EPAY
| $15.2M | 0.1% |
268,238
+165,658
| +161% | +$9.39M |
|
202
Bank of Montreal
BMO
$88.5B
| $15.1M | 0.1% |
128,324
-7,846
| -6% | -$924K |
|
203
Thomson Reuters
TRI
$80B
| $15.1M | 0.1% |
133,604
+63,172
| +90% | +$7.12M |
|
204
Cerence
CRNC
$419M
| $14.9M | 0.1% |
413,118
+132,070
| +47% | +$4.77M |
|
205
Zebra Technologies
ZBRA
$15.5B
| $14.5M | 0.1% |
35,064
+10,349
| +42% | +$4.28M |
|
206
Ryder
R
$7.59B
| $14.2M | 0.1% |
179,239
+111,385
| +164% | +$8.84M |
|
|
VG
207
DELISTED
Vonage Holdings Corporation
VG
| $13.8M | 0.09% |
682,040
+125,764
| +23% | +$2.55M |
|
208
Goldman Sachs
GS
$221B
| $13.6M | 0.09% |
41,300
+38,727
| +1,505% | +$12.8M |
|
209
Netflix
NFLX
$521B
| $13.6M | 0.09% |
36,336
+2,358
| +7% | +$883K |
|
|
TPTX
210
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $13.5M | 0.09% |
503,288
-72,200
| -13% | -$1.94M |
|
211
HP
HPQ
$26.8B
| $13.4M | 0.09% |
369,868
-267,976
| -42% | -$9.73M |
|
212
Robert Half
RHI
$3.78B
| $13.4M | 0.09% |
117,373
-146,365
| -55% | -$16.7M |
|
213
Becton Dickinson
BDX
$54.3B
| $13.3M | 0.09% |
51,250
-13,899
| -21% | -$3.61M |
|
214
Pacira BioSciences
PCRX
$1.22B
| $13.3M | 0.09% |
174,081
-56,000
| -24% | -$4.27M |
|
215
Wells Fargo
WFC
$258B
| $13.3M | 0.09% |
273,936
+770
| +0.3% | +$37.3K |
|
216
Cogent Biosciences
COGT
$1.83B
| $13.1M | 0.09% |
1,752,980
-112,792
| -6% | -$845K |
|
217
Cigna
CI
$80.2B
| $13.1M | 0.09% |
54,572
-2,269
| -4% | -$544K |
|
218
Humana
HUM
$37.5B
| $13M | 0.09% |
29,809
+5,964
| +25% | +$2.6M |
|
219
Ecolab
ECL
$77.5B
| $12.9M | 0.09% |
73,182
+10,676
| +17% | +$1.88M |
|
220
Union Pacific
UNP
$132B
| $12.9M | 0.09% |
47,144
+1,664
| +4% | +$455K |
|
221
Hilton Worldwide
HLT
$64.7B
| $12.5M | 0.09% |
82,382
-61,659
| -43% | -$9.36M |
|
222
IBM
IBM
$227B
| $12.4M | 0.08% |
95,662
+1,821
| +2% | +$237K |
|
223
Arrowhead Research
ARWR
$3.84B
| $12.4M | 0.08% |
270,054
+210,867
| +356% | +$9.7M |
|
224
Deere & Co
DE
$127B
| $12.3M | 0.08% |
29,659
-911
| -3% | -$378K |
|
225
Relay Therapeutics
RLAY
$709M
| $12.3M | 0.08% |
411,416
-118,469
| -22% | -$3.55M |
|